Home » Topics » Regulatory » Patents

Patents
RSS

GH secretatogues from Fujisawa

July 8, 1998

New immunosuppressants from Merck & Co. acting on potassium channels

July 8, 1998

Inhibitors of protein kinase GSK3 prepared at Chiron, U. of California

July 8, 1998

Cor Therapeutics describes selective factor Xa inhibitors

July 8, 1998

PDE V inhibitors for heart failure, impotence claimed by Merck KGaA

July 8, 1998

Investigation at Kowa results in development of potent CysLT1 receptor antagonists

July 7, 1998

Series of MMP and TACE inhibitors patented by American Cyanamid

July 7, 1998

ACAT inhibitors from SS Pharm. for atherosclerosis

July 7, 1998

Taisho claims potent and selective D4 receptor antagonists

July 7, 1998

Carcinostatic agents developed at Toagosei

July 7, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...